Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245285 | SCV000311041 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000055687 | SCV000638458 | benign | Holoprosencephaly 2 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000713305 | SCV000843895 | benign | not provided | 2017-10-25 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000713305 | SCV001157134 | benign | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713305 | SCV001894661 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 32022405) |
Fulgent Genetics, |
RCV002490634 | SCV002794618 | benign | Holoprosencephaly 2; Schizencephaly | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000713305 | SCV003916095 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | SIX3: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV000713305 | SCV005240686 | benign | not provided | criteria provided, single submitter | not provided | ||
Gene |
RCV000055687 | SCV000086602 | non-pathogenic | Holoprosencephaly 2 | 2013-08-29 | no assertion criteria provided | curation | Converted during submission to Benign. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000245285 | SCV002037427 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000245285 | SCV002038438 | benign | not specified | no assertion criteria provided | clinical testing |